Opioid equianalgesic conversion: the right dose
- PMID: 12690618
Opioid equianalgesic conversion: the right dose
Abstract
Ongoing diligent patient assessment is the most important step in the equianalgesic conversion process. The conversion must take into account individual patient characteristics such as age, renal function, side effects, and the patient's pain syndrome. In addition, if the opioid dose is not adequate to begin with, the conversion dose is less likely to be effective. In all situations, once the patient is converted, liberal titration and adjustment or individualized doses for each patient are required to ensure that the conversion transition is smooth and provides the patient with the analgesia needed to adequately manage the pain. Nurses play a major role in the assessment of patients receiving opioids for pain management. Inadequate pain management despite escalating doses, untoward side effects, loss of a route of administration, and sometimes cost and reimbursement issues necessitate an opioid conversion or rotation. Nurses also play a role in recommending the change and ensuring that patients receive the correct dose.
Similar articles
-
Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).Pain Pract. 2008 Jul-Aug;8(4):287-313. doi: 10.1111/j.1533-2500.2008.00204.x. Epub 2008 May 23. Pain Pract. 2008. PMID: 18503626
-
Multicenter, open-label, prospective evaluation of the conversion from previous opioid analgesics to extended-release hydromorphone hydrochloride administered every 24 hours to patients with persistent moderate to severe pain.Clin Ther. 2006 Jan;28(1):86-98. doi: 10.1016/j.clinthera.2006.01.010. Clin Ther. 2006. PMID: 16490582
-
Sustained-release oral morphine versus transdermal fentanyl and oral methadone in cancer pain management.Eur J Pain. 2008 Nov;12(8):1040-6. doi: 10.1016/j.ejpain.2008.01.013. Epub 2008 Mar 18. Eur J Pain. 2008. PMID: 18353696 Clinical Trial.
-
Clinical experience with transdermal and orally administered opioids in palliative care patients--a retrospective study.Jpn J Clin Oncol. 2007 Apr;37(4):302-9. doi: 10.1093/jjco/hym017. Epub 2007 May 22. Jpn J Clin Oncol. 2007. PMID: 17519302
-
[Treatment of pain in cancer with systemically administered opioids].Ned Tijdschr Geneeskd. 2001 May 19;145(20):950-4. Ned Tijdschr Geneeskd. 2001. PMID: 11396259 Review. Dutch.
Cited by
-
Advances in opioid therapy and formulations.Support Care Cancer. 2005 Mar;13(3):138-44. doi: 10.1007/s00520-004-0743-x. Epub 2004 Dec 14. Support Care Cancer. 2005. PMID: 15599600 Review.
-
Inches, Centimeters, and Yards: Overlooked Definition Choices Inhibit Interpretation of Morphine Equivalence.Clin J Pain. 2021 Aug 1;37(8):565-574. doi: 10.1097/AJP.0000000000000948. Clin J Pain. 2021. PMID: 34116543 Free PMC article.
-
Dose calculation in opioid rotation: electronic calculator vs. manual calculation.Int J Clin Pharm. 2011 Feb;33(1):25-32. doi: 10.1007/s11096-010-9464-z. Epub 2011 Jan 13. Int J Clin Pharm. 2011. PMID: 21365390
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical